INO4:05 PMPositive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in ChinaTrial Results • Phase 3inovio.com
INO4:05 PMINOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlightsinovio.com
INO4:05 PMINOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlightsinovio.com
INO4:05 PMINOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026inovio.com
INO8:05 AMINOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)inovio.com